Industry

DUBLIN–(BUSINESS WIRE)–The “Bioinformatics – Market Insights, Competitive Landscape and Market Forecast-2027” report has been added to ResearchAndMarkets.com’s offering. The global bioinformatics market was valued at USD 20.12 Billion in 2021, growing at a CAGR of 15.14% during the forecast period from 2022 to 2027 to reach USD 46.88 Billion by 2027. Companies Mentioned Agilent Technologies … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Logistics Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The Global Pharmaceutical Logistics market size is expected to show an annual growth rate of approximately 5% during the forecast period 2022-2027. Companies Mentioned Deutsche Post DHL Kuehne + Nagel UPS (Marken) … [Read more…]

Oncomine Dx Express Test and Oncomine Reporter Dx informatics combine with Ion Torrent Genexus Dx System to deliver clinically relevant biomarker results in as little as one day CARLSBAD, Calif.–(BUSINESS WIRE)–Next-generation sequencing (NGS) is quickly becoming the platform of choice for tumor molecular profiling due to its ability to simultaneously report on multiple biomarkers. However, … [Read more…]

The Phase 2 trial for the treatment of NASH met its primary efficacy endpoint; PXL065-treated patients achieved statistically significant improvements in the relative decrease in liver fat content measured by magnetic resonance imaging estimated proton density fat fraction (MRI-PDFF) at 36-weeks for all doses. Key secondary measures in PXL065-treated patients included a statistically significant improvement … [Read more…]

BEIJING & SAN DIEGO–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for the initiation of a Phase 1/2 clinical study of YH001 in combination with envafolimab and doxorubicin for the treatment … [Read more…]

BEIJING & SAN DIEGO–(BUSINESS WIRE)–#Biocytogen–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for the initiation of a Phase 1/2 clinical study of YH001 in combination with envafolimab and doxorubicin for the treatment … [Read more…]

BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, confirms that the Ontario Securities Commission (the “OSC”) has issued a failure to file cease trade order against the Company (“FTFCTO”) which orders that general trading, whether direct or indirect, by any person, of … [Read more…]

94 percent of MultiPlan employees say that people of all cultures, abilities, and backgrounds are respected and valued at MultiPlan NEW YORK–(BUSINESS WIRE)–$MPLN #MPLN—MultiPlan Corporation (NYSE:MPLN) (“MultiPlan” or the “Company”), a market-leading, technology-enabled provider of end-to-end healthcare cost management solutions, announced today its designation as a Great Place to Work-Certified™ company for 2022-2023. This distinction … [Read more…]

P3 Nevada Acquires Pahrump Cardiology & Family Practice PAHRUMP, Nev.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that P3 Health Partners-Nevada, LLC (“P3 Nevada”) is expanding its footprint in Nye County with the recent acquisition of a cardiology and multi-specialty practice. Pahrump Cardiology & Family … [Read more…]

MUMBAI, India–(BUSINESS WIRE)–#asia–Anuva (formerly known as Global Gene Corp) enters into its next stage of growth focused on creating the most diverse Genomic Bio / Data Bank at scale. To enable this, Anuva is entering into a global strategic partnership with Helix, the leading population genomics and viral surveillance company in the United States. Anuva … [Read more…]